LEADER 06084nam 2201633z- 450 001 9910367739603321 005 20210211 010 $a3-03921-705-4 035 $a(CKB)4100000010106321 035 $a(oapen)https://directory.doabooks.org/handle/20.500.12854/45089 035 $a(oapen)doab45089 035 $a(EXLCZ)994100000010106321 100 $a20202102d2019 |y 0 101 0 $aeng 135 $aurmn|---annan 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 00$aDietary Intake and Type 2 Diabetes 210 $cMDPI - Multidisciplinary Digital Publishing Institute$d2019 215 $a1 online resource (322 p.) 311 08$a3-03921-704-6 330 $aThe prevalence of diabetes is on the increase in the UK and worldwide, partly due to changes in lifestyle which predispose individuals to overweight and obesity. It is estimated that about 90% of the currently diagnosed adults have type 2 diabetes, and based on the World Health Organisation (WHO) report, about 422 million adults were living with diabetes in 2014 compared with 108 million in 1980; this condition caused about 1.5 million deaths in 2012. In the United States of America, it is estimated that about 30.3 million adults are living with diabetes, with a further 1.5 million new diabetes cases diagnosed every year, representing an increasing prevalence of this condition. Diabetes represents a major public health challenge, despite advances in technology and the pharmaceutical industry. These problems may be in the form of acute or long-term complications. Therefore, in order to attenuate the problems of diabetes, management strategies usually include lifestyle changes such as increased physical activity and dietary interventions. Studies which evaluate the role of nutrition in the management of type 2 diabetes often involve human and animal models as these approaches enable us to have a broader and more in-depth understanding of the condition. In some cases, diabetes may co-exist with other conditions, such as stroke, and these may present unique challenges with regard to nutritional interventions. This Special Issue aims to evaluate the risk factors associated with type 2 diabetes and the role of the diet in the management of people with this condition. This evidence is drawn from both human and animal studies. 606 $aBiology, life sciences$2bicssc 610 $a25-OH-D 610 $aaldosterone 610 $aalmond 610 $aAMPK 610 $aappendicular fat 610 $aappendicular lean 610 $aaronia 610 $abariatric surgery 610 $abody composition 610 $abody mass index 610 $acalcium intake 610 $acarbohydrate counting 610 $acarbohydrate restricted diet 610 $acardiovascular risk factors 610 $achronic conditions 610 $acohort study 610 $adairy products 610 $aDASH 610 $adiabetes 610 $adiabetes management 610 $adiabetes mellitus 610 $adiabetes reversal 610 $adiabetes specific formula 610 $adiet quality 610 $adietary intake 610 $adietary management approaches 610 $adietary pattern 610 $aenergy restricted diet 610 $aenteral nutrition 610 $aenteral tube feeding 610 $aepidemiology 610 $afasting blood glucose 610 $afeces 610 $afish 610 $afish oil 610 $afolk medicine 610 $afood 610 $afree fatty acids (FFA) 610 $agestational diabetes 610 $aginseng 610 $aglucose monitoring 610 $aglycaemic control 610 $aglycaemic index 610 $aglycated haemoglobin 610 $aglycated hemoglobin A 610 $aglycemic control 610 $aglycemic index 610 $agut microbiome 610 $aHedychium coronarium 610 $ahigh fat diet 610 $ahigh-density lipoprotein cholesterol 610 $ahyperglycemia 610 $aincretins 610 $ainflammatory parameters 610 $ainsulin dosage 610 $ainsulin resistance 610 $ainsulin secretion 610 $ainterleukin-6 610 $aisomaltulose 610 $aJapanese 610 $alactic acid bacteria 610 $alifestyle management 610 $alipid parameters 610 $alipid profile 610 $alipids 610 $alongitudinal analysis 610 $alow carbohydrate diet 610 $alow energy diet 610 $alow-carbohydrate 610 $amacronutrients 610 $ameta-analysis 610 $ametabolic syndrome 610 $amicronutrients 610 $amuscle 610 $amushroom 610 $anutrition 610 $anutritional supplement 610 $anuts 610 $aobesity 610 $apancreatectomy 610 $apeanut 610 $apolyunsaturated fatty acids 610 $aprediabetes 610 $aprotein and fat counting 610 $aPUFA 610 $arandomised controlled trial 610 $arosemary extract 610 $ashort chain fatty acids 610 $astandard formula 610 $astreptozotocin 610 $asubjective appetite 610 $asucromalt 610 $asystematic review 610 $aT2DM 610 $atempeh 610 $atotal body fat 610 $atotal body lean 610 $atrace elements 610 $atriglyceride 610 $atype 1 diabetes 610 $atype 2 diabetes 610 $atype 2 diabetes mellitus 610 $avegetable oil 610 $avery-low-calorie 610 $avitamin D 610 $avitamin D deficiency 610 $awomen 610 $azinc intake 610 $azinc status 615 7$aBiology, life sciences 700 $aOjo$b Omorogieva$4auth$01290995 906 $aBOOK 912 $a9910367739603321 996 $aDietary Intake and Type 2 Diabetes$93021734 997 $aUNINA